Asset Details
Do you wish to reserve the book?
Establishing US norms for the Adult ADHD Self‐Report Scale (ASRS‐v1.1) and characterising symptom burden among adults with self‐reported ADHD
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Establishing US norms for the Adult ADHD Self‐Report Scale (ASRS‐v1.1) and characterising symptom burden among adults with self‐reported ADHD
Do you wish to request the book?
Establishing US norms for the Adult ADHD Self‐Report Scale (ASRS‐v1.1) and characterising symptom burden among adults with self‐reported ADHD
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Establishing US norms for the Adult ADHD Self‐Report Scale (ASRS‐v1.1) and characterising symptom burden among adults with self‐reported ADHD
2019
Overview
Summary Aims To estimate Adult ADHD Self‐Report Scale (ASRS‐v1.1) Symptom Checklist normative total scores among the US adult general population and to evaluate overall attention‐deficit hyperactivity disorder (ADHD) symptom burden among US adults with ADHD. Methods Prior 2012 and 2013 US National Health and Wellness Survey respondents were re‐contacted. Demographics, comorbidities, and ASRS‐v1.1 data were collected. ASRS‐v1.1 scores were compared by sex, age, ADHD diagnosis, and ADHD medication use. Group differences were evaluated using chi‐square tests and independent samples t‐tests for categorical and continuous variables, respectively. Results Of 22 397 respondents, 465 self‐reported being diagnosed with ADHD by a physician; of these, 174 self‐reported using ADHD medication. The mean ASRS‐v1.1 total score was 2.0 (SD = 3.2); scores differed by age and sex (all, P < 0.001). ADHD (vs no ADHD) was associated with depression (58.1% vs 18.0%), anxiety (53.1% vs 16.0%), and sleep difficulties (37.0% vs 14.0%) (all, P < 0.001). ADHD medication use (vs no use) was associated with depression (68.4% vs 51.9%), anxiety (67.2% vs 44.7%), panic disorder (25.9% vs 17.2%), and insomnia (27.6% vs 19.6%) (all, P < 0.05). ADHD (vs no ADHD) respondents scored higher on all 18 ASRS‐v1.1 items (all, P < 0.05). Medication users (vs non‐users) scored higher on six items (all, P < 0.05). Discussion Adult ADHD may be undertreated or sub‐optimally treated, despite a high symptom burden. Normative data will allow comparisons with individuals’ scores to support the assessment of ADHD symptom burden among adults. Conclusion Findings highlight the importance of assessing ADHD symptom burden, especially among adults presenting with comorbidities.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
/ Adult
/ Adults
/ Aged
/ Anxiety
/ Attention Deficit Disorder with Hyperactivity - drug therapy
/ Attention Deficit Disorder with Hyperactivity - epidemiology
/ Attention deficit hyperactivity disorder
/ Female
/ Humans
/ Male
/ Panic Disorder - epidemiology
/ Psychiatric Status Rating Scales
/ Self
/ Sleep Initiation and Maintenance Disorders - epidemiology
